Topic Archives: AC Immune (ACIU)

April 30, 2020 / Travis Johnson, Stock Gumshoe

What’s that “First and Best Drugs” Alzheimer’s Stock for 300% gains?

I got several reader questions this week about a new recommendation from Dave Lashmet at Stansberry — it looks like this was issued as a recommendation for regular Stansberry Investment Advisory subscribers, not one of Lashmet’s more expensive biotech-focused newsletters, and it’s very light on clues… but let’s see if we can give you anything […]

December 21, 2015 / Michael Jorrin, "Doc Gumshoe"

Alzheimer’s Wrap-Up

[ed note: Michael Jorrin, who I like call “Doc Gumshoe,” is a longtime medical writer who shares his thoughts with us a couple times a month — his articles are non-financial in nature, his words and opinions are his own, and you can see his bio and his past pieces here. Enjoy!] Indulge me while […]

Comments

linling88 on Tropic of Palatin / Sep 25, 9:57pm

$ACIU: A new biotech IPO stock debuted last Friday, September 23: AC Immune, based in Switzerland, is a clinical-stag...

DrKSSMDPhD on Ten Common Biotech Investing Mistakes / Sep 18, 8:13am

Two biotech IPOs this week might be of some interest. I've personally not been participating in the biotech IPO market b...

DrKSSMDPhD on Quickster: The Long Case for Ignyta ($RXDX) / Jun 2, 9:04am

Krystyna: I know of AC Immune. My truthful feeling is that its clinical programs are also-rans. Little distinguishes th...

kmb0202 on Quickster: The Long Case for Ignyta ($RXDX) / Jun 2, 7:54am

Just read that a company called AC Immune has just filed its F-1 paperwork with the U.S. Securities & Exchange Commissio...